[1]王 钰,徐 琳,吕雅丽,等.扫描式葡萄糖监测系统在妊娠期糖尿病患者血糖管理中的应用[J].陕西医学杂志,2021,50(8):962-965.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.015]
　WANG Yu,XU Lin,LYU Yali,et al.Application of flash glucose monitoring in blood glucose management of pregnant women with gestational diabetes mellitus[J].,2021,50(8):962-965.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.015]
点击复制

扫描式葡萄糖监测系统在妊娠期糖尿病患者血糖管理中的应用
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年8期
页码:
962-965
栏目:
临床研究
出版日期:
2021-08-05

文章信息/Info

Title:
Application of flash glucose monitoring in blood glucose management of pregnant women with gestational diabetes mellitus
作者:
王 钰; 徐 琳; 吕雅丽; 李 娅; 李立立; 贺菲菲
(西安市人民医院 西安市第四医院,陕西 西安710004)
Author(s):
WANG Yu; XU Lin; LYU Yali; LI Ya; LI Lili; HE Feifei
(Xi'an People's Hospital,Xi'an 710004,China)
关键词:
扫描式葡萄糖监测;  妊娠期糖尿病;  空腹血糖;  餐后2 h血糖;  妊娠结局
Keywords:
Flash glucose monitoring;  Gestational diabetes mellitus;  Fasting plasma glucose;  2-hour postprandial glucose;  Pregnancy outcome
分类号:
R 714.7
DOI:
DOI:10.3969/j.issn.1000-7377.2021.08.015
文献标志码:
A
摘要:
目的:探讨扫描式葡萄糖监测(FGM)系统在妊娠期糖尿病患者血糖管理中的应用。方法:选取妊娠期糖尿病患者60例,随机分为两组,各30例,观察组采用FGM进行为期14 d的血糖监测,对照组采用指尖血糖监测,每天至少进行4次监测; 比较两组患者血糖达标时间、空腹血糖(FPG)、餐后2 h血糖(2hPG)、糖化血红蛋白(HbA1c)、低血糖发生情况、葡萄糖目标范围内时间(TIR)及妊娠结局情况。结果:两组孕妇血糖达标时间、FPG、2hPG、低血糖发生情况以及TIR比较差异均有统计学意义(均P<0.05),而两组糖化血红蛋白水平比较无统计学差异(P>0.05); 两组羊水异常、胎膜早破、胎盘早剥、早产、新生儿呼吸窘迫症、新生儿低血糖发生情况比较差异均无统计学意义(P>0.05),观察组孕妇的剖宫产率低于对照组(P< 0.05)。结论:FGM可以使妊娠期糖尿病孕妇血糖控制更加及时有效,降低孕妇的剖宫产率。
Abstract:
Objective:To investigate the application of flash glucose monitoring(FGM)in blood glucose management of patients with gestational diabetes mellitus.Methods:60 pregnant women with gestational diabetes mellitus were randomly divided into two groups,30 cases in each group.The observation group used FGM for 14-day blood glucose monitoring.The control group used finger tip blood glucose monitoring,at least 4 times a day.The time of blood glucose reaching the standard,fasting blood glucose(FPG),2-hour postprandial blood glucose(2hPG),glycosylated hemoglobin(HbA1c),incidence of hypoglycemia,time in range(TIR)and pregnancy outcome were compared between the two groups.Results:There were significant differences in the time of blood glucose reaching the standard,FPG,2hPG,incidence of hypoglycemia and TIR between the two groups(all P<0.05),but there was no significant difference in the level of HbA1c between the two groups(P>0.05).There were no significant differences in the incidence of abnormal amniotic fluid,premature rupture of membranes,placental abruption,premature delivery,neonatal respiratory distress and neonatal hypoglycemia between the two groups(all P>0.05).The cesarean section rate of the observation group was lower than that of the control group(P<0.05).Conclusion:FGM can make blood glucose control of pregnant women with gestational diabetes mellitus more timely and effective,and reduce the cesarean section rate of pregnant women.

参考文献/References:

[1] 高建瓴,刘 洪.妊娠中期维生素D水平降低与妊娠期糖尿病相关性研究进展[J].陕西医学杂志,2019,48(7):954-957.
[2] 蔡红霞,丁金玉,张明恩.四君子汤对妊娠期糖尿病患者血管内皮功能及妊娠结局的影响[J].陕西中医,2020,41(12):1708-1711.
[3] Yefet E,Schwartz N,Sliman B,et al.Good glycemic control of gestational diabetes mellitus is associated with the attenuation of future maternal cardiovascular risk:A retrospective cohort study[J].Cardiovasc Diabetol,2019,18(1):75.
[4] 周麦玲,郗 艳.孕期糖尿病治疗对围产期并发症影响研究[J].陕西医学杂志,2018,47(7):889-891,930.
[5] 刘 蔚,纪立农.从循证证据看扫描式葡萄糖监测技术的应用[J].中华糖尿病杂志,2018,10(10):637-639.
[6] American Diabetes Association.Management of diabetes in pregnancy:Standards of medical care in diabetes-2020[J].Diabetes Care,2020,43(1):183-192.
[7] 戴冬君,陆静毅,周 健.持续葡萄糖监测新指标:葡萄糖在目标范围内时间的临床意义解析[J].中华糖尿病杂志,2019,11(2):139-142.
[8] 吴红花.妊娠期高血糖人群的胰岛素应用[J].中华全科医师杂志,2019,18(1):14-17.
[9] 中华医学会糖尿病学分会血糖监测学组.中国扫描式葡萄糖监测技术临床应用专家共识[J].中华糖尿病杂志,2018,10(11):697-700.
[10] 王余娜,高显舜,姚可荣.妊娠期糖尿病患者血清维生素D、白细胞介素-17水平与胰岛素抵抗指数相关性研究[J].陕西医学杂志,2020,49(11):1429-1431,1439.
[11] Brown J,Martis R,Hughes B,et al.Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes[J].Cochrane Database Syst Rev,2017,25:11967.
[12] Szmuilowicz ED,Josefson JL,Metzger BE.Gestational diabetes mellitus[J].Endocrinol Metab Clin North Am,2019,48(3):479-493.
[13] Huhn EA,Linder T,Eppel D,et al.Effectiveness of real-time continuous glucose monitoring to improve glycaemic control and pregnancy outcome in patients with gestational diabetes mellitus:A study protocol for a randomised controlled trial[J].BMJ Open,2020,10(11):40498.
[14] 杨晓燕,任楠楠,张文香.妊娠糖尿病发病率及其相关危险因素分析[J].陕西医学杂志,2018,47(5):577-579.
[15] Scott EM,Bilous RW,Kautzky WA.Accuracy,user acceptability,and safety evaluation for the free style libre flash glucose monitoring system when used by pregnant women with diabetes[J].Diabetes Technology & Therapeutics,2018,20(3):180-188.
[16] Carlson AL,Mullen DM,Bergenstal RM.Clinical use of continuous glucose monitoring in adults with type 2 diabetes[J].Diabetes Technol Ther,2017,19(2):4-11.
[17] Laffel LM,Kanapka LG,Beck RW,et al.CGM intervention in teens and young adults with T1D(city)study group; CDE10.effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes:A randomized clinical trial[J].JAMA,2020,323(23):2388-2396.
[18] Battelino T,Danne T,Bergenstal RM,et al.Clinical targets for continuous glucose monitoring data interpretation:Recommendations from the international consensus on time in range[J].Diabetes Care,2019,42(8):1593-1603.
[19] Ang E,Lee ZX,Moore S,et al.Flash glucose monitoring(FGM):A clinical review on glycaemic outcomes and impact on quality of life[J].J Diabetes Complications,2020,34(6):107559.
[20] American Diabetes Association.Glycemic targets:Standards of medical care in diabetes-2020[J].Diabetes Care,2020,43(1):66-76.
[21] Rayis DA,Ahmed ABA,Sharif ME,et al.Reliability of glycosylated hemoglobin in the diagnosis of gestational diabetes mellitus[J].J Clin Lab Anal,2020,34(10):23435.

相似文献/References:

[1]魏小敏,王丽丽,刘海霞,等.丹参素通过STAT3/JAK2/SOCS1信号通路在妊娠期糖尿病干预中的作用机制研究[J].陕西医学杂志,2023,52(5):508.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.003]
　WEI Xiaomin,WANG Lili,LIU Haixia,et al.Mechanism of danshensu in gestational diabetes mellitus through STAT3/JAK2/SOCS1 signaling pathway[J].,2023,52(8):508.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.003]
[2]杨 静,郭 永,郭润民.孕早期孕妇促甲状腺激素、甲状腺过氧化物酶抗体及微小RNA-873-5p水平与妊娠期糖尿病相关性研究[J].陕西医学杂志,2024,(4):479.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.009]
　YANG Jing,GUO Yong,GUO Runmin.Correlation between TSH,TPOAb,miR-873-5p levels in early pregnancy and gestational diabetes mellitus[J].,2024,(8):479.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.009]

备注/Memo

备注/Memo:
基金项目:陕西省社会发展科技攻关项目(2016SF-101); 西安市第四医院科研孵化基金资助项目(FZ-21)
更新日期/Last Update: 2021-08-05